USA - NASDAQ:OPRX - US68401U2042 - Common Stock
The current stock price of OPRX is 21.68 USD. In the past month the price increased by 15.44%. In the past year, price increased by 297.07%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.33 | 48.03B | ||
| DOCS | DOXIMITY INC-CLASS A | 44.86 | 12.52B | ||
| WAY | WAYSTAR HOLDING CORP | 35.11 | 7.44B | ||
| HTFL | HEARTFLOW INC | N/A | 3.16B | ||
| CERT | CERTARA INC | 25.84 | 2.03B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.67B | ||
| SDGR | SCHRODINGER INC | N/A | 1.66B | ||
| PHR | PHREESIA INC | N/A | 1.41B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 11.29 | 1.37B | ||
| CTEV | CLARITEV CORP | N/A | 1.15B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
| EVH | EVOLENT HEALTH INC - A | N/A | 917.75M |
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Waltham, Massachusetts and currently employs 106 full-time employees. The company went IPO on 2005-05-18. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
OPTIMIZERX CORP
260 Charles Street, Suite 302
Waltham MASSACHUSETTS 48307 US
CEO: William Febbo
Employees: 129
Phone: 12486516558
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Waltham, Massachusetts and currently employs 106 full-time employees. The company went IPO on 2005-05-18. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
The current stock price of OPRX is 21.68 USD. The price increased by 10.67% in the last trading session.
OPRX does not pay a dividend.
OPRX has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The PE ratio for OPTIMIZERX CORP (OPRX) is 29.3. This is based on the reported non-GAAP earnings per share of 0.74 and the current share price of 21.68 USD.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on OPRX.
ChartMill assigns a technical rating of 10 / 10 to OPRX. When comparing the yearly performance of all stocks, OPRX is one of the better performing stocks in the market, outperforming 98.18% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to OPRX. OPRX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months OPRX reported a non-GAAP Earnings per Share(EPS) of 0.74. The EPS increased by 184.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -5.83% | ||
| ROE | -8.27% | ||
| Debt/Equity | 0.21 |
13 analysts have analysed OPRX and the average price target is 19.38 USD. This implies a price decrease of -10.61% is expected in the next year compared to the current price of 21.68.
For the next year, analysts expect an EPS growth of 105.03% and a revenue growth 18.13% for OPRX